Media Coverage

Quest Diagnostics and 98point6 have teamed up to make it easier for patients to connect with a doctor virtually about lab results.

Quest Diagnostics introduced a new blood test Wednesday to aid in determining if an individual has developed immunity to the coronavirus by either having had COVID-19 or being vaccinated for it.

Grail has tapped testing giant Quest Diagnostics to help roll out its upcoming multi-cancer blood test, expected to launch in the coming months.

Low-cost rapid COVID-19 testing is now more accessible across the city, thanks to a new testing program being rolled out by the state. It's part of Gov. Cuomo’s New York Forward Rapid Test Program. It will take place at select CVS, Quest Diagnostics and Clarity MedHealth mobile labs across New York City.

Quest Diagnostics officials announced this week that its turnaround times for COVID-19 testing are faster than at any other time during the pandemic — with the “vast majority” being turned around in one day.

Quest Diagnostics said Tuesday it is now sequencing 2,000 tests a week, doubling the amount of genomic sequencing it started performing last month. The company said it is sequencing the tests for the US Centers for Disease Control and Prevention.

Steve Rusckowski, Quest Diagnostics CEO, joins ‘Closing Bell’ to discuss coronavirus testing, covid variants, and his outlook on the pandemic as coronavirus cases decrease in the U.S.

Quest Diagnostics said Thursday that continued high demand for Covid-19 testing helped drive record revenue and earnings for the company in the fourth quarter and throughout 2020.

In this latest episode of the "MHE Talks: Improving Patient Access" series, Senior Editor of MHE, Peter Wehrwein, speaks with Harvey Kaufman, M.D., FCAP, MBA, senior medical director of medical informatics at Quest Diagnostics. The two discussed a recent Quest Diagnostics Health Trends report examining healthcare disparities.

A new Quest Diagnostics survey found Black and Latino Americans are nearly two times as likely as white Americans to say their access to COVID-19 vaccines - when available - would be worse than other racial or ethnic groups.